Use of inhaled corticosteroids and healthcare costs in mild persistent asthma.

@article{Colice2007UseOI,
  title={Use of inhaled corticosteroids and healthcare costs in mild persistent asthma.},
  author={Gene L. Colice and Eric Qiong Wu and Howard Birnbaum and Maham Daher and Marynchenko Maryna},
  journal={The Journal of asthma : official journal of the Association for the Care of Asthma},
  year={2007},
  volume={44 6},
  pages={479-83}
}
Healthcare costs were determined for mild persistent asthma patients (n=796) who used inhaled corticosteroids infrequently (0 to 2 claims) or consistently (3 or more claims). Study patients, selected from a privately insured claims database (1999-2003), had at least one asthma diagnosis, no diagnosis of chronic obstructive pulmonary disease (COPD), and mild persistent asthma as defined by the 2005 Health Plan Employer Data and Information Set (HEDIS), Leidy's reliever and oral steroid methods… CONTINUE READING